Skip to main content
Basic Technical IVT

BCC

Also written as: BCC — Basal Cell Carcinoma

Standard abbreviation for Basal Cell Carcinoma, widely used in dermatology pathology reports, referral letters, and clinical trials.

Full Definition

BCC is the universally recognised abbreviation for Basal Cell Carcinoma in dermatology and oncology documentation. It should be introduced by spelling out the full term at first use, followed by BCC in parentheses, with the abbreviation used consistently thereafter. Editors should be aware that BCC may also appear as 'blind carbon copy' in email communication footers; within a clinical document, context will distinguish the two, but editorial vigilance is required. Subtype qualifiers (nodular BCC, superficial BCC, morphoeic BCC) should be retained in full in pathology reports.

Usage

Usage note: Define at first use. Retain subtype qualifiers (nodular, superficial, morphoeic) alongside the abbreviation in pathology contexts.

In Context

  • "The patient has a history of two excised BCCs on the left temple within the past five years." — Oncology follow-up letter
  • "Vismodegib is indicated for locally advanced BCC not amenable to surgery or radiotherapy." — Prescribing information summary

Also known as

Basal Cell Carcinoma

Don't confuse with

SCC (squamous cell carcinoma) MCC (Merkel cell carcinoma)

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON